A detailed history of Gds Wealth Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Gds Wealth Management holds 2,725 shares of ABBV stock, worth $486,112. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,725
Previous 2,725 -0.0%
Holding current value
$486,112
Previous $467,000 15.2%
% of portfolio
0.05%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 24, 2024

SELL
$159.82 - $182.1 $126,257 - $143,859
-790 Reduced 22.48%
2,725 $496,000
Q4 2023

Feb 06, 2024

BUY
$137.6 - $154.97 $162,368 - $182,864
1,180 Added 50.54%
3,515 $544,000
Q3 2023

Oct 19, 2023

SELL
$133.59 - $154.65 $3,606 - $4,175
-27 Reduced 1.14%
2,335 $348,000
Q2 2023

Jul 27, 2023

SELL
$132.51 - $164.9 $60,954 - $75,854
-460 Reduced 16.3%
2,362 $318,000
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $408,089 - $469,975
2,822 New
2,822 $449,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Gds Wealth Management Portfolio

Follow Gds Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gds Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Gds Wealth Management with notifications on news.